Altered arginine metabolism in Alzheimer's disease brains

Neurobiology of Aging

Volumn 35, Issue 9, 2014, Pages 1992-2003

  Liu, Ping ^a   Fleete, Michael S ^a   Jing, Yu ^a   Collie, Nicola D ^a   Curtis, Maurice A ^b   Waldvogel, Henry J ^b   Faull, Richard L M ^b   Abraham, Wickliffe C ^a   Zhang, Hu ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Aging; Alzheimer's disease; Arginase; Nitric oxide synthase; Polyamines; Urea cycle

Indexed keywords

4 AMINOBUTYRIC ACID; AGMATINE; ARGINASE; ARGININE; CITRULLINE; GLUTAMIC ACID; GLUTAMINE; NITRIC OXIDE SYNTHASE; ORNITHINE; PUTRESCINE; SPERMIDINE; SPERMINE;

ADULT; AGED; AGING; ALZHEIMER DISEASE; AMINO ACID BRAIN LEVEL; AMINO ACID METABOLISM; ARTICLE; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPERIOR FRONTAL GYRUS; VERY ELDERLY; ANTIBODY SPECIFICITY; DISEASE COURSE; ENZYMOLOGY; METABOLISM; PREFRONTAL CORTEX;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; ARGINASE; ARGININE; CEREBELLUM; DISEASE PROGRESSION; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; ORGAN SPECIFICITY; PREFRONTAL CORTEX;

EID: 84902112745     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.03.013     Document Type: Article

References (89)

1. Aliev G., Palacios H.H., Lipsitt A.E., Fischbach K., Lamb B.T., Obrenovich M.E., Morales L., Gasimov E., Bragin V. Nitric oxide as an initiator of brain lesions during the development of Alzheimer disease. Neurotox. Res. 2009, 16:293-305.
2. Alm K., Oredsson S. Cells and polyamines do it cyclically. Essays Biochem. 2009, 46:63-76.
3. Arlt S., Schulze F., Eichenlaub M., Maas R., Lehmbeck J.T., Schwedhelm E., Jahn H., Böger R.H. Asymmetrical dimethylarginine is increased in plasma and decreased in cerebrospinal fluid of patients with Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2008, 26:58-64.
4. Austin S.A., Santhanam A.V., Katusic Z.S. Endothelial nitric oxide modulates expression and processing of amyloid precursor protein. Circ. Res. 2010, 107:1498-1502.
5. Bensemain F., Hot D., Ferreira S., Dumont J., Bombois S., Maurage C.A., Huot L., Hermant X., Levillain E., Hubans C., Hansmannel F., Chapuis J., Hauw J.J., Schraen S., Lemoine Y., Buee L., Berr C., Mann D., Pasquier F., Amouyel P., Lambert J.C. Evidence for induction of the ornithine transcarbamylase expression in Alzheimer's disease. Mol. Psychiatry 2009, 14:106-116.
6. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
7. Bradford M.M. Arapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
8. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. U.S.A 1990, 87:682-685.
9. Cho D.H., Nakamura T., Fang J., Cieplak P., Godzik A., Gu Z., Lipton S.A. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 2009, 324:102-105.
10. Colton C.A., Mott R.T., Sharpe H., Xu Q., Van Nostrand W.E., Vitek M.P. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J.Neuroinflammation 2006, 3:27.
11. de la Torre J.C. Cerebral hemodynamics and vascular risk factors: setting the stage for Alzheimer's disease. J.Alzheimers Dis. 2012, 32:553-567.
12. de la Torre J.C., Stefano G.B. Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide. Brain Res. Rev. 2000, 34:119-136.
13. Ellison D.W., Beal M.F., Mazurek M.F., Bird E.D., Martin J.B. Apostmortem study of amino acid neurotransmitters in Alzheimer's disease. Ann. Neurol. 1986, 20:616-621.
14. Feil R., Kleppisch T. NO/cGMP-dependent modulation of synaptic transmission. Handb. Exp. Pharmacol. 2008, 184:529-560.
15. Felipo V., Butterworth R.F. Neurobiology of ammonia. Prog. Neurobiol. 2002, 67:259-279.
16. Fisman M., Gordon B., Feleki V., Helmes E., Appell J., Rabheru K. Hyperammonemia in Alzheimer's disease. Am. J. Psychiatry 1985, 142:71-73.
17. Forstermann U., Sessa W.C. Nitric oxide synthases: regulation and function. Eur. Heart J. 2012, 33:829-837. 837a-837d.
18. Foxton R.H., Land J.M., Heales S.J. Tetrahydrobiopterin availability in Parkinson's and Alzheimer's disease; potential pathogenic mechanisms. Neurochem. Res. 2007, 32:751-756.
19. Gupta N., Jing Y., Collie N.D., Zhang H., Liu P. Ageing alters behavioural function and brain arginine metabolism in male Sprague-Dawley rats. Neuroscience 2012, 226C:178-196.
20. Halaris A., Plietz J. Agmatine : metabolic pathway and spectrum of activity in brain. CNS Drugs 2007, 21:885-900.
21. Hansmannel F., Sillaire A., Kamboh M.I., Lendon C., Pasquier F., Hannequin D., Laumet G., Mounier A., Ayral A.M., DeKosky S.T., Hauw J.J., Berr C., Mann D., Amouyel P., Campion D., Lambert J.C. Is the urea cycle involved in Alzheimer's disease?. J.Alzheimers Dis. 2010, 21:1013-1021.
22. Hardy J.A., Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992, 256:184-185.
23. Igarashi K., Kashiwagi K. Modulation of cellular function by polyamines. Int. J. Biochem. Cell Biol. 2010, 42:39-51.
24. Ishigami A., Ohsawa T., Hiratsuka M., Taguchi H., Kobayashi S., Saito Y., Murayama S., Asaga H., Toda T., Kimura N., Maruyama N. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease. J.Neurosci. Res. 2005, 80:120-128.
25. Jeynes B., Provias J. Significant negative correlations between capillaryexpressed eNOS and Alzheimer lesion burden. Neurosci. Lett. 2009, 463:244-248.
26. Joshi M.S., Ferguson T.B., Johnson F.K., Johnson R.A., Parthasarathy S., Lancaster J.R. Receptor-mediated activation of nitric oxide synthesis by arginine in endothelial cells. Proc. Natl. Acad. Sci. U.S.A 2007, 104:9982-9987.
27. Kalaria R.N., Akinyemi R., Ihara M. Does vascular pathology contribute to Alzheimer changes?. J.Neurol. Sci. 2012, 322:141-147.
28. Knox L.T., Jing Y., Fleete M.S., Collie N.D., Zhang H., Liu P. Scopolamine impairs behavioural function and arginine metabolism in the rat dentate gyrus. Neuropharmacology 2011, 61:1452-1462.
29. Larner A.J. The cerebellum in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 1997, 8:203-209.
30. Law A., Gauthier S., Quirion R. Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type. Brain Res. Brain Res. Rev. 2001, 35:73-96.
31. Leitch B., Shevtsova O., Reusch K., Bergin D.H., Liu P. Spatial learning-induced increase in agmatine levels at hippocampal CA1 synapses. Synapse 2011, 65:146-153.
32. Li G., Regunathan S., Barrow C.J., Eshraghi J., Cooper R., Reis D.J. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 1994, 263:966-969.
33. Liu P., Chary S., Devaraj R., Jing Y., Darlington C.L., Smith P.F., Tucker I.G., Zhang H. Effects of aging on agmatine levels in memory-associated brain structures. Hippocampus 2008, 18:853-856.
34. Liu P., Collie N.D., Chary S., Jing Y., Zhang H. Spatial learning results in elevated agmatine levels in the rat brain. Hippocampus 2008, 18:1094-1098.
35. Liu P., Gupta N., Jing Y., Zhang H. Age-related changes in polyamines in memory-associated brain structures in rats. Neuroscience 2008, 155:789-796.
36. Liu P., Jing Y., Collie N.D., Campbell S.A., Zhang H. Pre-aggregated Abeta(25-35) alters arginine metabolism in the rat hippocampus and prefrontal cortex. Neuroscience 2011, 193:269-282.
37. Liu P., Jing Y., Collie N.D., Chary S., Zhang H. Memory-related changes in L-citrulline and agmatine in the rat brain. Hippocampus 2009, 19:597-602.
38. Liu P., Jing Y., Zhang H. Age-related changes in arginine and its metabolites in memory-associated brain structures. Neuroscience 2009, 164:611-628.
39. Liu P., Smith P.F., Appleton I., Darlington C.L., Bilkey D.K. Nitric oxide synthase and arginase in the rat hippocampus and the entorhinal, perirhinal, postrhinal, and temporal cortices: regional variations and age-related changes. Hippocampus 2003, 13:859-867.
40. Liu P., Smith P.F., Appleton I., Darlington C.L., Bilkey D.K. Regional variations and age-related changes in nitric oxide synthase and arginase in the sub-regions of the hippocampus. Neuroscience 2003, 119:679-687.
41. Liu P., Smith P.F., Appleton I., Darlington C.L., Bilkey D.K. Hippocampal nitric oxide synthase and arginase and age-associated behavioral deficits. Hippocampus 2005, 15:642-655.
42. Liu P., Zhang H., Devaraj R., Ganesalingam G.S., Smith P.F. Amultivariate analysis of the effects of aging on glutamate, GABA and arginine metabolites in the rat vestibular nucleus. Hear. Res. 2010, 269:122-133.
43. Lundberg J.O., Weitzberg E., Gladwin M.T. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat. Rev. Drug Discov. 2008, 7:156-167.
44. Luth H.J., Holzer M., Gartner U., Staufenbiel M., Arendt T. Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology. Brain Res. 2001, 913:57-67.
45. Malaterre J., Strambi C., Aouane A., Strambi A., Rougon G., Cayre M. Anovel role for polyamines in adult neurogenesis in rodent brain. Eur. J. Neurosci. 2004, 20:317-330.
46. Malinski T. Nitric oxide and nitroxidative stress in Alzheimer's disease. J.Alzheimers Dis. 2007, 11:207-218.
47. Marques F., Sousa J.C., Sousa N., Palha J.A. Blood-brain-barriers in aging and in Alzheimer's disease. Mol. Neurodegener. 2013, 8:38.
48. Milsom A.B., Fernandez B.O., Garcia-Saura M.F., Rodriguez J., Feelisch M. Contributions of nitric oxide synthases, dietary nitrite/nitrate, and other sources to the formation of NO signaling products. Antioxid. Redox Signal 2012, 17:422-432.
49. Mohlake P., Whiteley C.G. Arginine metabolising enzymes as therapeutic tools for Alzheimer's disease: peptidyl arginine deiminase catalyses fibrillogenesis of beta-amyloid peptides. Mol. Neurobiol. 2010, 41:149-158.
50. Morris S.M. Regulation of enzymes of the urea cycle and arginine metabolism. Annu. Rev. Nutr. 2002, 22:87-105.
51. Morrison L.D., Cao X.C., Kish S.J. Ornithine decarboxylase in human brain: influence of aging, regional distribution, and Alzheimer's disease. J.Neurochem. 1998, 71:288-294.
52. Morrison L.D., Kish S.J. Brain polyamine levels are altered in Alzheimer's disease. Neurosci. Lett. 1995, 197:5-8.
53. Norris P.J., Faull R.L., Emson P.C. Neuronal nitric oxide synthase (nNOS) mRNA expression and NADPH-diaphorase staining in the frontal cortex, visual cortex and hippocampus of control and Alzheimer's disease brains. Brain Res. Mol. Brain Res. 1996, 41:36-49.
54. Orsucci D., Mancuso M., Ienco E.C., Simoncini C., Siciliano G., Bonuccelli U. Vascular factors and mitochondrial dysfunction: a central role in the pathogenesis of Alzheimer's disease. Curr. Neurovasc. Res. 2013, 10:76-80.
55. Piletz J.E., Aricioglu F., Cheng J.-T., Fairbanks C.A., Gilad V.H., Haenisch B., Halaris A., Hong S., Lee J.E., Li J., Liu P., Molderings G.J., Rodrigues A.L.S., Satriano J., Seong G.J., Wilcox G., Wu N., Gilad G.M. Agmatine: clinical applications after 100 years in translation. Drug Discov Today 2013, 18:880-893.
56. Provias J., Jeynes B. Neurofibrillary tangles and senile plaques in Alzheimer's brains are associated with reduced capillary expression of vascular endothelial growth factor and endothelial nitric oxide synthase. Curr. Neurovasc. Res. 2008, 5:199-205.
57. Reis D.J., Regunathan S. Is agmatine a novel neurotransmitter in brain?. Trends Pharmacol. Sci. 2000, 21:187-193.
58. Rock D.M., Macdonald R.L. Polyamine regulation of N-methyl-D-aspartate receptor channels. Annu. Rev. Pharmacol. Toxicol. 1995, 35:463-482.
59. Rushaidhi M., Jing Y., Zhang H., Liu P. Participation of hippocampal agmatine in spatial learning: an invivo microdialysis study. Neuropharmacology 2013, 65:200-205.
60. Santhanam A.V., Viswanathan S., Dikshit M. Activation of protein kinase B/Akt and endothelial nitric oxide synthase mediates agmatine-induced endothelium-dependent relaxation. Eur. J. Pharmacol. 2007, 572:189-196.
61. Satriano J. Agmatine: at the crossroads of the arginine pathways. Ann. N.Y. Acad. Sci. 2003, 1009:34-43.
62. Seiler N. Ammonia and Alzheimer's disease. Neurochem. Int. 2002, 41:189-207.
63. Selkoe D.J. Alzheimer's disease. Cold Spring Harb. Perspect. Biol. 2011, 3. pii: a004457.
64. Selley M.L. Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease. Neurobiol. Aging 2003, 24:903-907.
65. Seo S., Liu P., Leitch B. Spatial learning-induced accumulation of agmatine and glutamate at hippocampal CA1 synaptic terminals. Neuroscience 2011, 192:28-36.
66. Serrano-Pozo A., Frosch M.P., Masliah E., Hyman B.T. Neuropathological alterations in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2011, 1:a006189.
67. Sun J., Zhang X., Broderick M., Fein H. Measurement of nitric oxide production in biological systems by using Griess reaction assay. Sensors 2003, 3:276-284.
68. Susswein A.J., Katzoff A., Miller N., Hurwitz I. Nitric oxide and memory. Neuroscientist 2004, 10:153-162.
69. Tapiero H., Mathe G., Couvreur P., Tew K.D. II. Glutamine and glutamate. Biomed. Pharmacother. 2002, 56:446-457.
70. Thorns V., Hansen L., Masliah E. nNOS expressing neurons in the entorhinal cortex and hippocampus are affected in patients with Alzheimer's disease. Exp. Neurol. 1998, 150:14-20.
71. Toda N., Okamura T. Cerebral blood flow regulation by nitric oxide in Alzheimer's disease. J.Alzheimers Dis. 2012, 32:569-578.
72. Tousoulis D., Kampoli A.M., Tentolouris C., Papageorgiou N., Stefanadis C. The role of nitric oxide on endothelial function. Curr. Vasc. Pharmacol. 2012, 10:4-18.
73. Trushina E., Dutta T., Persson X.M., Mielke M.M., Petersen R.C. Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics. PLoS One 2013, 8:e63644.
74. Trushina E., Mielke M.M. Recent advances in the application of metabolomics to Alzheimer's disease. Biochim. Biophys. Acta 2013, pii: S0925-4439(13)00223-8.
75. Tumani H., Shen G., Peter J.B., Bruck W. Glutamine synthetase in cerebrospinal fluid, serum, and brain: a diagnostic marker for Alzheimer disease?. Arch. Neurol. 1999, 56:1241-1246.
76. Vodovotz Y., Lucia M.S., Flanders K.C., Chesler L., Xie Q.W., Smith T.W., Weidner J., Mumford R., Webber R., Nathan C., Roberts A.B., Lippa C.F., Sporn M.B. Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J.Exp. Med. 1996, 184:1425-1433.
77. Waldvogel H.J., Bullock J.Y., Synek B.J., Curtis M.A., van Roon-Mom W.M., Faull R.L. The collection and processing of human brain tissue for research. Cell Tissue Bank 2008, 9:169-179.
78. Waldvogel H.J., Curtis M.A., Baer K., Rees M.I., Faull R.L. Immunohistochemical staining of post-mortem adult human brain sections. Nat. Protoc. 2006, 1:2719-2732.
79. Wallace H.M. The polyamines: past, present and future. Essays Biochem. 2009, 46:1-9.
80. Wallace H.M., Fraser A.V., Hughes A. Aperspective of polyamine metabolism. Biochem. J. 2003, 376:1-14.
81. Wegiel J., Wisniewski H.M., Dziewiatkowski J., Badmajew E., Tarnawski M., Reisberg B., Mlodzik B., De Leon M.J., Miller D.C. Cerebellar atrophy in Alzheimer's disease-clinicopathological correlations. Brain Res. 1999, 818:41-50.
82. Wiesinger H. Arginine metabolism and the synthesis of nitric oxide in the nervous system. Prog. Neurobiol. 2001, 64:365-391.
83. Xiong Y., Yuan L.W., Deng H.W., Li Y.J., Chen B.M. Elevated serum endogenous inhibitor of nitric oxide synthase and endothelial dysfunction in aged rats. Clin. Exp. Pharmacol. Physiol. 2001, 28:842-847.
84. Wong A., Luth H.J., Deuther-Conrad W., Dukic-Stefanovic S., Gasic-Milenkovic J., Arendt T., Munch G. Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease. Brain Res. 2001, 920:32-40.
85. Wu G., Morris S.M. Arginine metabolism: nitric oxide and beyond. Biochem. J. 1998, 336:1-17.
86. Yew D.T., Wong H.W., Li W.P., Lai H.W., Yu W.H. Nitric oxide synthase neurons in different areas of normal aged and Alzheimer's brains. Neuroscience 1999, 89:675-686.
87. Yi J., Horky L.L., Friedlich A.L., Shi Y., Rogers J.T., Huang X. L-arginine and Alzheimer's disease. Int. J. Clin. Exp. Pathol. 2009, 2:211-238.
88. Zhou L., Zhu D.Y. Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications. Nitric Oxide 2009, 20:223-230.
89. Zolman J.F. Biostatistics: Experimental Design and Statistical Inference 1993, Oxford University Press, Oxford, UK.